It’s not every day that a baby is born in the Brigham and Women’s Hospital (BWH) cardiovascular hybrid operating room (OR), but that’s where a multidisciplinary cardiovascular and obstetrics team was at the ready as 29-year-old Chelsea Phaneuf delivered her daughter, Aria, this spring. Chelsea had been admitted to the Shapiro Cardiovascular Center with a failing heart valve about a month before Aria’s arrival.
At the age of 23, an echocardiogram showed that Chelsea’s bicuspid valve had suddenly deteriorated and needed to be replaced. At such a young age, Chelsea was concerned about how the surgery would impact planning for a future family. The daily blood-thinning medication required for patients who undergo a valve replacement with a mechanical device is a risk to a developing fetus. Chelsea, therefore, opted for a biological valve, even though they don’t last as long as a mechanical valve.